BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37801533)

  • 1. Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic.
    Borash J; Bunick CG; Graber E
    J Drugs Dermatol; 2023 Oct; 22(10):1061. PubMed ID: 37801533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline.
    Graber E; Kay CR
    J Drugs Dermatol; 2021 Jan; 20(1):98-100. PubMed ID: 33400418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.
    Grada A; Ghannoum MA; Bunick CG
    Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
    Armstrong AW; Hekmatjah J; Kircik LH
    J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Impetigo in the Pediatric Population: Consensus and Future Directions.
    Schachner LA; Torrelo A; Grada A; Micali G; Kwong PC; Scott GB; Benjamin L; Gonzalez ME; Andriessen A; Eberlein T; Eichenfield LF
    J Drugs Dermatol; 2020 Mar; 19(3):281-290. PubMed ID: 32550690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
    Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
    J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarecycline Review.
    Haidari W; Bruinsma R; Cardenas-de la Garza JA; Feldman SR
    Ann Pharmacother; 2020 Feb; 54(2):164-170. PubMed ID: 31462063
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Impetigo and Antimicrobial Resistance.
    Schachner LA; Lynde CW; Kircik LH; Torrelo A; Hohl D; Kwong P; Oza V; Andriessen A; Hebert AA
    J Drugs Dermatol; 2021 Apr; 20(4):366-372. PubMed ID: 33852242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials.
    Del Rosso JQ; Stein Gold L; Baldwin H; Harper JC; Zeichner J; Obagi S; Graber E; Jimenez X; Vicente FH; Grada A
    J Drugs Dermatol; 2021 Jun; 20(6):634-640. PubMed ID: 34076386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarecycline hydrochloride for the treatment of acne vulgaris.
    Kaul G; Saxena D; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Oct; 55(10):615-625. PubMed ID: 31720559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
    Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
    J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2021 Feb; 22(2):145-154. PubMed ID: 32924666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Microbiome and Antimicrobial Stewardship in Surgical Patients.
    Creel JP; Maves RC
    Surg Infect (Larchmt); 2023 Apr; 24(3):220-225. PubMed ID: 37010965
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic stewardship and empirical antibiotic treatment: How can they get along?
    Zuccaro V; Columpsi P; Sacchi P; LucĂ  MG; Fagiuoli S; Bruno R
    Dig Liver Dis; 2017 Jun; 49(6):579-584. PubMed ID: 28215515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
    Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A
    J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship.
    Kaupitwa CJ; Nowaseb S; Godman B; Kibuule D
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1365-1379. PubMed ID: 35912881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparing for the New Joint Commission Requirements: a Model for Tracking Outcomes of an Ambulatory Antibiotic Stewardship Program in Primary Care.
    Hempel EV; Duca N; Kipp R; van Harskamp J; Caputo G
    J Gen Intern Med; 2021 Mar; 36(3):762-766. PubMed ID: 33420558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome.
    Batool Z; Lomakin IB; Polikanov YS; Bunick CG
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20530-20537. PubMed ID: 32817463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Infusion Nurse's Role in Antibiotic Stewardship.
    Morgan SA
    J Infus Nurs; 2019; 42(2):75-80. PubMed ID: 30817423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.